Cell line development is crucial for Contract Development and Manufacturing Organizations (CDMOs) specializing in antibody production. The efficiency and quality of cell lines directly impact the yield, functionality, and scalability of the biotherapeutics produced. Selecting the right host cell and optimizing the expression system are pivotal steps in ensuring high productivity and quality. This process involves the stable uptake of genetic material, clone selection, and rigorous screening to identify the highest-producing cell lines, thus expediting the pathway from drug discovery to clinical application.
Creative Biolabs offers a suite of cell line development services that cater to various stages of biologics development. Our services are designed to provide high-producing, stable cell lines tailored to the unique requirements of each project. Our expertise spans multiple cell types, including CHO (Chinese Hamster Ovary) cells, which are widely regarded as the gold standard for therapeutic protein production.
We provide commercial licensing for high-performance host cell lines, which are optimized for high yield and stability, ensuring efficient production processes.
Our mammalian cell line development service includes gene synthesis, vector construction, transfection, and clone screening. We utilize advanced technologies like automated high-throughput screening to identify top-performing cell lines.
To ensure the long-term stability of cell lines, we conduct rigorous passage stability evaluations. This includes assessing the genetic stability and consistency of protein expression over multiple generations.
We offer comprehensive cell bank storage and stability evaluation services. This includes the establishment of master and working cell banks, as well as long-term storage solutions compliant with regulatory standards.
Our antibody production cell line development service is designed to generate high-yielding cell lines for monoclonal antibody production. We focus on optimizing both upstream and downstream processes to maximize productivity and product quality.
Creative Biolabs offers ADCC enhanced cell line development services. This involves engineering cell lines to produce antibodies with improved ADCC activity, which is crucial for the efficacy of certain therapeutic antibodies.
We provide full-service cell bank establishment, including thorough testing and characterization. This ensures that the cell banks meet all regulatory requirements and are ready for clinical and commercial use.
Our cell line development services are pivotal in various applications, including:
Q1: What usually uses the CHO cell line as the preferred choice for biopharmaceutical production?
A1: CHO (Chinese Hamster Ovary) cells have several advantages that make them the preferred choice for biopharmaceutical production, such as expression capability, scalability, regulatory Approval.
Q2: What is the typical timeline for cell line development at Creative Biolabs?
A2: We pride ourselves on efficiency. Our cell line development process typically spans four months from gene synthesis to the creation of a stable Research Cell Bank (RCB), although exact timelines depend on specific project requirements.
Creative Biolabs remains committed to driving innovation in cell line development, ensuring that our clients have access to the highest quality cell lines for their biopharmaceutical endeavors. Our holistic approach integrates cutting-edge technologies, robust processes, and expert knowledge, enabling us to deliver top-tier services that meet the dynamic needs of the industry.
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.